The stock of Twist Bioscience Corp (TWST) has seen a -9.11% decrease in the past week, with a 8.19% gain in the past month, and a -11.72% decrease in the past quarter. The volatility ratio for the week is 4.41%, and the volatility levels for the past 30 days are at 5.46% for TWST. The simple moving average for the last 20 days is -3.74% for TWST stock, with a simple moving average of 3.48% for the last 200 days.
Is It Worth Investing in Twist Bioscience Corp (NASDAQ: TWST) Right Now?
The stock has a 36-month beta value of 1.77. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TWST is 56.09M, and at present, short sellers hold a 15.94% of that float. On October 04, 2024, the average trading volume of TWST was 872.33K shares.
TWST) stock’s latest price update
Twist Bioscience Corp (NASDAQ: TWST) has seen a decline in its stock price by -1.13 in relation to its previous close of 43.28. However, the company has experienced a -9.11% decline in its stock price over the last five trading sessions. businesswire.com reported 2024-08-27 that SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10 at 2:35 p.m. Eastern Time. The presentation will be webcast live and can be accessed by visiting the “I.
Analysts’ Opinion of TWST
Many brokerage firms have already submitted their reports for TWST stocks, with Guggenheim repeating the rating for TWST by listing it as a “Buy.” The predicted price for TWST in the upcoming period, according to Guggenheim is $53 based on the research report published on June 04, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see TWST reach a price target of $45, previously predicting the price at $25. The rating they have provided for TWST stocks is “Buy” according to the report published on January 17th, 2024.
Berenberg gave a rating of “Buy” to TWST, setting the target price at $27 in the report published on September 27th of the previous year.
TWST Trading at -6.54% from the 50-Day Moving Average
After a stumble in the market that brought TWST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.74% of loss for the given period.
Volatility was left at 5.46%, however, over the last 30 days, the volatility rate increased by 4.41%, as shares surge +6.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.66% lower at present.
During the last 5 trading sessions, TWST fell by -9.11%, which changed the moving average for the period of 200-days by +23.63% in comparison to the 20-day moving average, which settled at $44.59. In addition, Twist Bioscience Corp saw 16.09% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TWST starting from Green Paula, who proposed sale 3,310 shares at the price of $43.21 back on Oct 02 ’24. After this action, Green Paula now owns shares of Twist Bioscience Corp, valued at $143,027 using the latest closing price.
Cho Dennis, the Officer of Twist Bioscience Corp, proposed sale 3,104 shares at $43.21 during a trade that took place back on Oct 02 ’24, which means that Cho Dennis is holding shares at $134,126 based on the most recent closing price.
Stock Fundamentals for TWST
Current profitability levels for the company are sitting at:
- -0.64 for the present operating margin
- 0.41 for the gross margin
The net margin for Twist Bioscience Corp stands at -0.75. The total capital return value is set at -0.34. Equity return is now at value -38.36, with -30.42 for asset returns.
Based on Twist Bioscience Corp (TWST), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.8. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is -189969.0.
Currently, EBITDA for the company is -193.21 million with net debt to EBITDA at 0.99. When we switch over and look at the enterprise to sales, we see a ratio of 7.98. The receivables turnover for the company is 8.95for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.91.
Conclusion
To sum up, Twist Bioscience Corp (TWST) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
